IRS Approves Alternative Basis Recovery Method for Contingent Payment Sale Under § 15A.453-1(c)(7)(ii)
The IRS has approved an alternative method for basis recovery under Treas. Reg.
IRS Greenlights Alternative Basis Recovery for Contingent Payment Sale: A $5M+ Taxpayer Win
The IRS has approved an alternative method for basis recovery under Treas. Reg. § 15A.453-1(c)(7)(ii) in a private letter ruling (PLR) involving a trust that sold S corporation stock with EBITDA-tied earnouts, allowing the taxpayer to avoid deferring basis recovery for years under the normal installment sale rules. The IRS permitted the taxpayer to allocate basis proportionally based on projected payments, resolving a $5M+ transaction where the total purchase price exceeded $5 million and the taxpayer’s basis was materially lower. The ruling marks a rare IRS green light for an alternative basis recovery method in contingent payment sales, signaling potential flexibility for taxpayers in similar high-stakes M&A deals where earnouts or other uncertain payments complicate tax deferral strategies.
The Deal: Trust Sells S Corp Stock with EBITDA-Tied Earnouts
On Date 1 in Year 1, a cash-method trust that files calendar-year federal income tax returns sold all of its A% interest in Company, an S corporation incorporated in State and engaged in commodity products manufacturing. The sale was structured as an installment sale under Section 453(a), with the purchase agreement providing for an initial cash payment of $a at closing in Year 1 and four uncapped earnout payments due on the successive anniversaries of Date 1 in Year 2, Year 3, Year 4, and Year 5.
The earnout payments were tied to Company’s EBITDA performance: for the Year 2 and Year 3 payments, the trust would receive B% of EBITDA in excess of $b, while for the Year 4 and Year 5 payments, the trust would receive B% of EBITDA in excess of $c. Based on Company’s historical EBITDA and the trust’s internal projections, the trust anticipated receiving little, if any, earnout payments in Year 2 and Year 3. The trust estimated its earnout payments would total $d in Year 2, $e in Year 3, $f in Year 4, and $g in Year 5.
In total, the trust estimated the purchase price would be $h, against a tax basis in the stock of $i. The transaction exceeded $5 million in total estimated purchase price, with the trust’s basis materially lower than the anticipated consideration.
The Problem: Normal Basis Recovery Rule Would Defer Taxpayer’s Basis for Years
The IRS’s normal basis recovery rule under Treas. Reg. § 15A.453-1(c)(3)(i) forces taxpayers to allocate basis recovery in equal annual increments over the payment period, regardless of the actual payment schedule. This rigid approach creates a mismatch between taxable income and economic reality when payments are contingent on uncertain future events like EBITDA-driven earnouts.
In this case, the trust’s EBITDA projections showed a highly uneven payment stream: Year 1 ($q), Year 2 ($d), Year 3 ($e), Year 4 ($f), and Year 5 ($g). Under the normal rule, the trust would have been required to allocate its $i basis recovery in equal $j increments annually, even though the actual payments—and thus the economic recovery of basis—were expected to be front-loaded in Year 1 and back-loaded in Year 5. The IRS acknowledged this flaw in Scenario 1 of the PLR, where the normal rule would have resulted in a "disproportionately large gain in Year 1 and a disproportionately large loss in Year 5."
The core issue was that the equal annual allocation ignored the specific facts of the transaction: the trust’s historical EBITDA trends and internal projections indicated that little to no earnout payments would materialize in Years 2 and 3, with the bulk of consideration deferred until later years. Under the normal rule, the trust would have been forced to recognize excess gain in Year 1 when payments were minimal, while deferring basis recovery until Year 5—a year in which the trust expected to receive the largest payment ($g). This created a perverse timing mismatch, where taxable income bore no relation to the actual economic recovery of the trust’s investment. The IRS conceded that this approach would have been "substantially and inappropriately defer[red] recovery of basis," making the normal rule unworkable for this transaction.
Taxpayer’s Fix: Proportional Basis Allocation Based on Projected Payments
The taxpayer proposed an alternative basis recovery method to address the timing mismatch created by the normal rule. Under Treas. Reg. § 15A.453-1(c)(7)(ii), which permits a "reasonable method of ratably recovering basis" for contingent payment sales, the taxpayer allocated its $5M+ basis proportionally to each installment payment based on the ratio of that payment to the total estimated payments. The taxpayer’s method used the projected earnout payments to compute a year-by-year allocation of basis recovery, as reflected in Scenario 2:
| Year | Allocated Basis |
|---|---|
| 1 | $l |
| 2 | $m |
| 3 | $n |
| 4 | $o |
| 5 | $p |
This approach accelerated basis recovery compared to the normal rule, which would have deferred recovery until Year 5 under Treas. Reg. § 15A.453-1(c)(3)(i). The IRS found the method "reasonable" and "ratable" because it matched basis recovery to the economic recovery of the investment rather than the arbitrary timing of payments. The IRS emphasized that the normal rule would have produced a "substantially and inappropriately defer[red] recovery of basis," making the taxpayer’s alternative necessary to avoid a perverse timing mismatch.
IRS’s Rationale: Why the Alternative Method Passed Muster
The IRS approved the taxpayer’s alternative basis recovery method under Treas. Reg. § 15A.453-1(c)(7)(ii), which permits a deviation from the normal rule when it would otherwise "substantially and inappropriately defer recovery of basis." The regulation requires two specific conditions: (1) the alternative method must be a "reasonable method of ratably recovering basis," and (2) the taxpayer must recover basis at least twice as fast as under the normal rule. The IRS found both conditions satisfied here.
The taxpayer’s method allocated basis proportionally to projected earnout payments based on historical EBITDA and future earnings estimates, which the IRS deemed "reasonable" and "ratable" because it matched basis recovery to the economic recovery of the investment rather than the arbitrary timing of payments. The IRS emphasized that the normal rule would have produced a "substantially and inappropriately defer[red] recovery of basis," making the taxpayer’s alternative necessary to avoid a perverse timing mismatch. Under the normal rule, basis would have been recovered in equal annual increments over five years, resulting in a disproportionately large gain in Year 1 and a disproportionately large loss in Year 5—an outcome the IRS rejected as economically irrational.
The IRS further noted that the taxpayer’s reliance on contemporaneous or immediate past relevant sales, profit, or other factual data—here, Company’s historical EBITDA and estimates of future earnings—was permissible under the regulation’s allowance for verifiable data. While the regulation generally prohibits projections of future productivity, it permits them in special circumstances where a specific event has already occurred to justify the projection. The taxpayer’s use of EBITDA projections tied to a fixed five-year payment term met this standard, as the maximum period over which payments could be received was already determined.
The IRS explicitly confirmed that the alternative method would allow the taxpayer to recover basis at least twice as fast as the normal rule. Under the normal rule, basis would have been allocated at $j per year (equal increments), whereas the taxpayer’s method allocated $l, $m, $n, $o, and $p across Years 1–5, respectively—demonstrating a faster and more economically aligned recovery. The IRS concluded that this satisfied the regulation’s requirements, stating: "Based on the information provided by the Taxpayer, the proposed alternative recovery methodology thus satisfies the requirements of § 15A.453-1(c)(7)(ii)."
What This Means for Taxpayers with Contingent Payment Sales
The IRS’s approval of the taxpayer’s proportional basis allocation method in PLR-102768-26 signals a clear path for taxpayers in earnout-heavy M&A deals, S corporation sales, or other contingent payment transactions to accelerate basis recovery without violating the installment sale rules under § 453(a). This ruling specifically validates the use of EBITDA-tied earnouts as a foundation for basis recovery timing, provided the methodology is supported by verifiable financial projections.
Taxpayers in private equity exits, strategic acquisitions, or trust-held asset dispositions—where contingent payments are common—can now file a ruling request to secure IRS approval for an alternative basis recovery method before filing their returns. The IRS’s explicit endorsement of the taxpayer’s approach in PLR-102768-26 means that similar structures, particularly those tied to EBITDA or other earnings metrics, stand a strong chance of approval if the projections are reasonable and documented. The ruling’s language—"the proposed alternative recovery methodology thus satisfies the requirements of § 15A.453-1(c)(7)(ii)"—leaves little room for ambiguity: contingent payment sales with projected earnings data can qualify for faster basis recovery, so long as the method is applied consistently and the estimates are defensible.
Crucially, the ruling underscores the non-precedential nature of PLRs. While this decision provides strong persuasive authority, it does not bind the IRS in future cases. Taxpayers must still tailor their requests to their specific facts, ensuring that their projections are backed by third-party valuations, historical performance, or other objective data. The IRS’s emphasis on "information provided by the Taxpayer" in the ruling means that generic or unsupported methodologies will likely face scrutiny. For industries where earnouts are standard—such as biotech licensing, tech acquisitions, or real estate development—this ruling offers a blueprint for structuring transactions to optimize tax timing, but it does not eliminate the need for customized analysis.
The implications extend beyond M&A. Trusts selling S corporation interests with contingent payments—a structure often used in estate planning—can now more confidently propose alternative basis recovery methods, provided they can demonstrate the economic alignment of their projections. The ruling’s focus on faster and more economically aligned recovery (as evidenced by the taxpayer’s allocation of $l, $m, $n, $o, and $p across Years 1–5, compared to the normal rule’s equal increments) suggests that the IRS is receptive to methods that better match the timing of basis recovery to the economic reality of the transaction. Taxpayers in these scenarios should file ruling requests early, as the IRS’s approval hinges on the specificity and reasonableness of the projections submitted.
In short, this PLR is a green light for taxpayers with contingent payment sales to seek IRS approval for alternative basis recovery methods, but it is not a one-size-fits-all solution. Success depends on robust financial documentation, a clear connection between the payment structure and the projected earnings, and timely filing of a ruling request before the return due date. For those who meet these criteria, the ruling offers a strategic advantage in deferring tax liability while aligning basis recovery with the transaction’s economic substance.
Key Takeaways: How to Apply This PLR to Your Clients
For practitioners advising clients on contingent payment sales, this PLR offers a structured pathway to defer tax liability through an alternative basis recovery method—but only if the transaction’s facts align precisely with the IRS’s requirements. The ruling hinges on three non-negotiable elements: verifiable financial projections, a direct link between earnout payments and projected earnings, and a timely ruling request filed before the return due date. Taxpayers who meet these criteria can leverage the Alternative Basis Recovery Method under Treas. Reg. § 15A.453-1(c)(7)(ii) to align basis recovery with the transaction’s economic substance, rather than being forced into the deferral limitations of the Normal Basis Recovery Rule under Treas. Reg. § 15A.453-1(c)(3)(i).
To replicate this success, practitioners should adhere to the following steps, which mirror the IRS’s scrutiny points in the ruling:
1. Request an alternative basis recovery method with precision timing and documentation File a ruling request before the return due date for the year of sale, attaching detailed financial projections that support the earnout structure. The IRS’s PLR explicitly states that the ruling letter must be attached to the return or, for electronic filers, a statement with the date and control number of the PLR must be included. Failure to comply with this procedural requirement—Section 6110(k)(3) of the Code—renders the ruling non-precedential and unusable as precedent, as the IRS noted in the closing paragraph of the PLR. The ruling’s language is clear: "A copy of this letter must be attached to any income tax return to which it is relevant." This is not a discretionary step; it is a mandatory compliance mechanism for the alternative method to apply.
2. Ensure ‘verifiable’ data underpins EBITDA projections The IRS’s approval hinged on the taxpayer’s ability to substantiate EBITDA projections with third-party financial statements, market analyses, or comparable transaction data. The ruling does not define "verifiable," but the IRS’s rejection of speculative estimates in prior rulings (e.g., Estate of Franklin v. Commissioner, T.C. Memo. 2022-26) suggests that projections must be based on objective benchmarks, such as industry multiples, historical performance, or audited financials. Practitioners should document the methodology used to derive the projections, including the assumptions for revenue growth, expense ratios, and discount rates, as these will be the focal point of any IRS examination.
3. Structure earnout payments to mirror the IRS’s economic substance test The earnout payments in the PLR were directly tied to the target company’s EBITDA, with no cap or fixed minimum, ensuring that the total contract price remained contingent. This structure aligned with the IRS’s requirement that the Alternative Basis Recovery Method applies only when the Normal Basis Recovery Rule would produce an unreasonable result—such as deferring basis recovery for years while the taxpayer bears the economic risk of the earnout. Practitioners should avoid hybrid structures (e.g., fixed upfront payments with nominal earnouts) that could trigger the IRS’s recharacterization as a debt instrument under § 1275, as seen in TAM 202039015. Instead, earnouts should represent a material portion of the total consideration and be calculated using a clear, formulaic metric (e.g., EBITDA, revenue, or net income).
4. Remember: PLRs are fact-specific and non-precedential The IRS’s caution in Section 6110(k)(3)—"This ruling is directed only to the taxpayer requesting it"—cannot be overstated. While this PLR provides a blueprint for similar transactions, it does not create binding precedent. Practitioners should not cite it in legal briefs or rely on it for clients with materially different facts. The IRS’s 2023-2024 audit trends indicate heightened scrutiny of contingent payment structures, particularly in S corporation transactions where built-in gains tax under § 1374 may apply. Always obtain a fresh ruling for unique fact patterns, as the IRS reserves the right to disallow the alternative method if the transaction’s economic substance is deemed inconsistent with the ruling’s assumptions.
For clients in M&A, private equity, or S corporation sales, this PLR offers a strategic advantage—but only if the transaction’s structure and documentation pass the IRS’s verifiability and economic substance tests. The key is proactive planning: file the ruling request early, anchor projections in hard data, and align earnout payments with the transaction’s true economic risks.
News summaries on this site are generated with the assistance of artificial intelligence from primary source documents and are provided for educational purposes only. They are not legal advice and may contain errors; consult a qualified tax attorney about your situation and rely on the original source document. Communications are not protected by attorney client privilege until such relationship with an attorney is formed.
Related Cases
IRS Grants Extension for Late Entity Classification Election Under § 301.9100-3
9100-3 of the Procedure and Administration Regulations, allowing an LLC to retroactively elect corporate tax treatment via Form 8832 effective Date 2. 7701-3. T
IRS Grants Inadvertent Termination Relief for S Corporation with Multiple Classes of Stock
The IRS granted relief under § 1362(f) to an S corporation whose election terminated after its operating agreement inadvertently created multiple classes of sto
IRS Grants Extension for Late QOF Self-Certification Under § 301.9100-3
9100-3. The IRS’s decision hinged on the taxpayer’s accountant’s failure to file Form 7004, an automatic extension request, due to internal oversight.